GO:0042772 DNA damage response, signal transduction resulting in transcription: Signaling Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0042772 describes the biological process in which cells detect DNA damage and convert that signal into new gene transcription.
• The process is not a single pathway but a signaling cascade that couples DNA damage sensors to transcription factors and RNA polymerases.
• Key molecular players include ATM, p53, RNA-binding proteins, and chromatin-modifying complexes that together reprogram gene expression after damage.
• Defects in this process are linked to cancer, neurodegeneration, and premature ovarian insufficiency.
• CRISPR knockout, point-mutation, knock-in, and overexpression models are essential to dissect cause-and-effect relationships within this pathway.
• EDITGENE provides end-to-end CRISPR cell model and library screening services to study GO:0042772 at scale.
Description
DNA damage response, signal transduction resulting in transcription (GO:0042772) is the biological process that connects the detection of damaged DNA to the induction of new gene expression. When cells encounter DNA lesions, they must not only repair the damage but also reprogram transcription to produce protective proteins, cell-cycle regulators, and repair factors. This process is a cascade of signaling events that ultimately activates transcription factors and modulates RNA polymerase activity. Understanding GO:0042772 is critical because it sits at the interface of genome maintenance and gene regulation, and its dysregulation contributes to cancer, neurodegeneration, and reproductive disorders. Researchers study this term to identify the sensors, transducers, and effectors that convert a DNA lesion into a transcriptional response.
DNA damage response, signal transduction resulting in transcription At A Glance
| GO ID | GO:0042772 |
|---|---|
| GO term | DNA damage response, signal transduction resulting in transcription |
| Ontology | biological_process |
| Synonym | None |
| Major function | Couples DNA damage detection to transcriptional induction |
| Key upstream sensors | ATM, ATR, DNA-PK |
| Key transcription effectors | p53, NF-kB, RNA polymerase II |
| Cellular outcome | Reprogrammed gene expression for repair, survival, or apoptosis |
What Is GO:0042772?
GO:0042772 is defined as a cascade of processes initiated in response to the detection of DNA damage, and resulting in the induction of transcription. In other words, it is the signaling route from a DNA lesion to the activation of gene expression, rather than the repair of the damage itself or the transcription of a specific gene.
Why Is DNA damage response, signal transduction resulting in transcription Important in Cell Biology?
GO:0042772 is important because it explains how cells convert a physical DNA lesion into a gene expression program that determines whether a cell survives, repairs, or dies. This process is central to cancer biology, where tumor cells often hijack or disable damage-induced transcription to resist therapy. It is also relevant to neurodegeneration, where impaired damage signaling contributes to neuronal loss, and to reproductive disorders such as premature ovarian insufficiency.
• Determines cell fate after DNA damage by inducing pro-survival or pro-apoptotic genes.
• Links genome integrity to gene expression programs.
• Frequently dysregulated in breast cancer and other tumors.
• Contributes to neurodegeneration when signaling is impaired.
• Involved in premature ovarian insufficiency and reproductive aging.
• Provides targets for cancer therapy that exploit damage-induced transcription.
• Requires RNA-binding proteins for post-transcriptional coordination.
• Can be studied with CRISPR screens to identify novel regulators.
• Relevant to Fanconi anemia/BRCA pathway crosstalk.
• Offers biomarkers for DNA-damaging chemotherapy response.
What Happens During DNA damage response, signal transduction resulting in transcription?
DNA damage detection and sensor activation
In simple terms: First, the cell notices that its DNA is broken.
The process begins when sensor proteins recognize DNA lesions and activate apical kinases such as ATM. This activation is influenced by chromatin state, which can either facilitate or impede damage signaling. RNA-binding proteins also participate in early damage recognition and coordinate downstream events.
Signal transduction to transcription factors
In simple terms: The alarm is passed to proteins that turn genes on.
Activated ATM and related kinases phosphorylate downstream effectors, including transcription factors like p53, leading to their stabilization and activation. This step converts the damage signal into a transcriptional command. The Fanconi anemia/BRCA pathway can also intersect with these signaling events through ubiquitination and splicing regulation.
Chromatin remodeling and promoter accessibility
In simple terms: The cell opens up the DNA so genes can be read.
Chromatin state is a critical determinant of damage-induced transcription; ATM signaling can alter chromatin accessibility to permit transcription factor binding. This remodeling ensures that the correct genes are induced at the right time.
Transcriptional induction and RNA polymerase II activation
In simple terms: The gene-reading machine is switched on.
The final stage is the induction of transcription, often through RNA polymerase II recruitment and elongation. This results in the production of mRNAs that encode repair proteins, cell-cycle regulators, and survival factors. The process is tightly regulated to avoid inappropriate gene expression.
Key Genes Involved in GO:0042772 DNA damage response, signal transduction resulting in transcription
The following genes and proteins are central to the signaling cascade from DNA damage to transcription, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| ATM | Apical kinase that initiates damage signaling to transcription | Central regulator of GO:0042772; target for cancer therapy |
| TP53 | Transcription factor activated by damage signals | Most studied effector of damage-induced transcription |
| RNF4 | Polyubiquitination regulator of Fanconi anemia/BRCA pathway | Links ubiquitination to damage signaling and transcription |
| MST1 | Regulates mitochondrial DNA transcription and ROS pathway | Implicated in Alzheimer's disease and mitochondrial homeostasis |
| CCAR1 | Splicing factor regulating Fanconi anemia/BRCA pathway | Connects RNA processing to damage response |
| ESR1 | Estrogen receptor signaling crosstalk with DNA damage response | Relevant to breast tumorigenesis |
| RNA-binding proteins | Coordinate post-transcriptional events in damage response | Broad family with roles in GO:0042772 |
| BRCA1/2 | Fanconi anemia/BRCA pathway components | Defects cause hereditary cancers |
| FANC proteins | Fanconi anemia pathway | Targets for cancer and bone marrow failure research |
| PI3K-Akt | Pathway mediating mitochondrial DNA transcription | Therapeutic target in neurodegeneration |
| NF-kB | Transcription factor induced by damage | Inflammatory and survival signaling |
| RNA polymerase II | Executes transcription after damage signaling | Final effector of GO:0042772 |
| Chromatin remodelers | Modulate accessibility for transcription | Epigenetic regulators of damage response |
| Splicing factors | Process RNA after damage-induced transcription | Emerging players in genome stability |
| DNA-PK | Sensor kinase in damage response | Target for radiosensitization |
| ATR | Kinase responding to replication stress | Critical for replication-associated damage signaling |
| p21 (CDKN1A) | Cell-cycle inhibitor induced by p53 | Readout of damage-induced transcription |
| MDM2 | Negative regulator of p53 | Modulates strength of transcriptional response |
How Is DNA damage response, signal transduction resulting in transcription Regulated?
GO:0042772 is regulated at multiple levels. Chromatin state directly influences ATM signaling and the efficiency of damage-induced transcription. RNA-binding proteins provide post-transcriptional control that shapes the final gene expression output. The Fanconi anemia/BRCA pathway, regulated by RNF4-mediated polyubiquitination and CCAR1 splicing, can modulate the damage response. Estrogen receptor signaling also crosstalks with DNA damage response pathways in breast tissue.
DNA damage response, signal transduction resulting in transcription and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| ATM | Cancer, ataxia-telangiectasia | Knockout cell lines, point-mutation models |
| TP53 | Cancer, Li-Fraumeni syndrome | Knock-in of mutant p53, knockout |
| RNF4 | Fanconi anemia/BRCA pathway defects | Knockout and overexpression models |
| MST1 | Alzheimer's disease | Knockout and overexpression in neuronal cells |
| CCAR1 | Fanconi anemia/BRCA pathway defects | Knockout and splicing reporter models |
Cancer
Deregulated DNA damage response signaling and transcription are hallmarks of breast tumorigenesis, where estrogen receptor signaling intersects with damage response pathways. Defects in the Fanconi anemia/BRCA pathway, regulated by RNF4 and CCAR1, predispose to cancer. Targeting damage-induced transcription is a therapeutic strategy.
Neurodegeneration
MST1 regulates mitochondrial DNA transcription and the PI3K-Akt-ROS pathway, and is a novel therapeutic target for Alzheimer's disease. Impaired damage signaling contributes to neuronal loss.
Reproductive disorders
Single-nucleus and spatial transcriptomics of paediatric ovary revealed dysregulated signaling pathways underlying premature ovarian insufficiency in classic galactosemia, implicating damage response and transcription networks.
From DNA damage response, signal transduction resulting in transcription-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X regulate damage-induced transcription? | CRISPR knockout cell line |
| Does a specific mutation in gene X alter signaling? | Point-mutation knock-in |
| Does tagging gene X affect its localization? | Tagged knock-in |
| Does overexpression of gene X enhance transcription? | Overexpression cell line |
| Which genes are essential for GO:0042772? | Genome-wide CRISPR library screening |
| What is the transcriptional output after damage? | RNA-seq and bioinformatics analysis |
How to Study the DNA damage response, signal transduction resulting in transcription Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Global transcriptional changes after DNA damage | Identify induced genes in GO:0042772 |
| Phosphoproteomics | Kinase signaling events | Map ATM substrate networks |
| ChIP-seq | Transcription factor binding sites | Locate p53 or NF-kB promoters |
| CRISPR knockout screen | Gene essentiality for damage response | Discover novel regulators |
| Single-nucleus RNA-seq | Cell-type-specific transcription | Study ovarian or neuronal tissues |
| Spatial transcriptomics | Transcript location in tissue | Analyze disease microenvironments |
| Western blot | Protein expression and phosphorylation | Validate signaling activation |
| Immunofluorescence | Protein localization and foci | Assess damage foci and transcription factor nuclear import |
Transcriptomics
RNA-seq measures the induction of transcription after DNA damage, providing a global view of GO:0042772 output. Single-nucleus and spatial transcriptomics can resolve cell-type-specific responses.
Proteomics and phosphoproteomics
Mass spectrometry identifies phosphorylation events and protein interactions in the damage signaling cascade. This reveals how ATM and downstream kinases transmit signals to transcription factors.
Imaging and reporter assays
Fluorescent reporters and live-cell imaging track transcription factor localization and promoter activity after damage. These methods visualize the kinetics of GO:0042772.
CRISPR screens
Genome-wide CRISPR knockout screens identify genes required for damage-induced transcription. Focused screens can validate candidates from the Fanconi anemia/BRCA pathway.
How CRISPR Can Be Used to Study GO:0042772 DNA damage response, signal transduction resulting in transcription
Knockout
CRISPR knockout of candidate genes such as ATM or TP53 abolishes damage-induced transcription, allowing researchers to test necessity in GO:0042772. Knockout cell lines are foundational for loss-of-function studies.
Point Mutation
Point-mutation knock-in can mimic disease-associated mutations in genes like TP53 or RNF4, revealing how specific residues affect signaling to transcription. This approach distinguishes catalytic from scaffolding functions.
Knock-in
Tagged knock-in of genes such as ATM or RNA-binding proteins enables live-cell imaging and proteomic pull-down without altering endogenous regulation. This preserves physiological expression levels.
Overexpression
Overexpression of genes like MST1 or CCAR1 can amplify or dysregulate damage-induced transcription, modeling gain-of-function states in disease. Overexpression models are useful for screening downstream effects.
How EDITGENE Supports DNA damage response, signal transduction resulting in transcription Research
Researchers studying DNA damage response, signal transduction resulting in transcription-related genes often need to determine whether a candidate gene is causally involved in the pathway or merely correlated with it. EDITGENE provides the CRISPR cell models and screening services required to establish causality and mechanism.
Contact EDITGENE today to design your custom CRISPR model for DNA damage response, signal transduction resulting in transcription research.
Frequently Asked Questions About DNA damage response, signal transduction resulting in transcription
What is GO:0042772?
GO:0042772 is the biological process of DNA damage response, signal transduction resulting in transcription, where cells detect DNA damage and induce gene expression.
What genes are involved in DNA damage response, signal transduction resulting in transcription?
Key genes include ATM, TP53, RNF4, MST1, CCAR1, and BRCA1/2, among others.
How is GO:0042772 regulated?
It is regulated by chromatin state, ATM signaling, RNA-binding proteins, and ubiquitination pathways.
What diseases are linked to GO:0042772?
Cancer, neurodegeneration, and premature ovarian insufficiency are linked to defects in this process.
What methods study DNA damage-induced transcription?
RNA-seq, phosphoproteomics, ChIP-seq, and CRISPR screens are commonly used.
Why is ATM important in GO:0042772?
ATM is an apical kinase that initiates signaling to transcription factors after DNA damage.
How does p53 contribute to GO:0042772?
p53 is a transcription factor activated by damage signals that induces cell-cycle arrest and repair genes.
Can CRISPR screens identify new regulators of GO:0042772?
Yes, genome-wide CRISPR screens have identified genes required for damage-induced transcription.
What is the role of RNA-binding proteins in GO:0042772?
They coordinate post-transcriptional events that shape the transcriptional response to damage.
How does chromatin state affect GO:0042772?
Chromatin state influences ATM signaling and the accessibility of promoters for transcription.
Conclusion
GO:0042772 captures the essential link between DNA damage detection and transcriptional reprogramming. This process is fundamental to cell fate decisions and is implicated in cancer, neurodegeneration, and reproductive disorders. Continued research using CRISPR models and multi-omics will uncover new therapeutic targets within this pathway.
References
- 2. Salas-Armenteros I et al.. 2025. Crosstalk between chromatin state and ATM signalling in DNA damage-induced transcription stress.. EMBO J 44(19):5564-5594 PMID: 40859031
- 3. Xie J et al.. 2015. RNF4-mediated polyubiquitination regulates the Fanconi anemia/BRCA pathway.. J Clin Invest 125(4):1523-32 PMID: 25751062
- 4. Cui D et al.. 2024. MST1, a novel therapeutic target for Alzheimer's disease, regulates mitochondrial homeostasis by mediating mitochondrial DNA transcription and the PI3K-Akt-ROS pathway.. J Transl Med 22(1):1056 PMID: 39578795
- 5. Kai M. 2016. Roles of RNA-Binding Proteins in DNA Damage Response.. Int J Mol Sci 17(3):310 PMID: 26927092
- 6. Kavarthapu R et al.. 2024. Single-nucleus and spatial transcriptomics of paediatric ovary: Molecular insights into the dysregulated signalling pathways underlying premature ovarian insufficiency in classic galactosemia.. Clin Transl Med 14(10):e70043 PMID: 39440457
- 7. Harada N et al.. 2024. The splicing factor CCAR1 regulates the Fanconi anemia/BRCA pathway.. Mol Cell 84(14):2618-2633.e10 PMID: 39025073
- 8. Rajan A et al.. 2021. Deregulated estrogen receptor signaling and DNA damage response in breast tumorigenesis.. Biochim Biophys Acta Rev Cancer 1875(1):188482 PMID: 33260050
